This inventor holds 6 USPTO granted patents. Top assignees: Chiron Corporation, Chiron S.r.l., Novartis Vaccines and Diagnostics Srl. Active years: 1999-2010.
Company Filing History:
4 out of 672 
1 out of 19 
1 out of 47 Years Active: 1999-2010
Title: Innovator Massimo Bugnoli: Pioneering Advances in Immunology
Introduction: Massimo Bugnoli, an accomplished inventor located in Monteriggioni, Italy, has made significant contributions to the field of immunology. With a remarkable portfolio of six patents, his work focuses on innovative approaches to vaccines and treatments involving cytotoxins and immunodominant antigens.
Latest Patents: Among his recent patents, Bugnoli has developed a groundbreaking invention that provides polynucleotides encoding cytotoxin associated immunodominant antigen. These polynucleotides serve as vital tools for identifying complementary target nucleotide sequences. Furthermore, his invention includes kits and vectors containing these innovative polynucleotides. Another notable patent involves the creation of polypeptides of cytotoxin associated immunodominant (CAI) antigen. This invention not only offers prophylactic and therapeutic vaccines that incorporate CAI polypeptides but also outlines methods for their preparation and treatment of infections using these advanced vaccines.
Career Highlights: Throughout his career, Massimo Bugnoli has worked at prominent companies such as Chiron S.p.a. and Chiron S.r.l., where he has made invaluable contributions to research and development in immunological products.
Collaborations: Bugnoli has also collaborated with esteemed colleagues in the field, including Rino Rappuoli and Antonello Covacci. Their collective expertise has undoubtedly augmented the advancements in immunology and vaccine development.
Conclusion: With a solid foundation in research and numerous patents to his name, Massimo Bugnoli stands out as a significant innovator in the field of immunology. His inventions regarding cytotoxins and immunodominant antigens have the potential to revolutionize treatments and vaccines, leaving a lasting impact on medical science.